347 related articles for article (PubMed ID: 32556712)
1. Late complications and quality of life assessment for survivors receiving allogeneic hematopoietic stem cell transplantation.
Cheon J; Lee YJ; Jo JC; Kweon K; Koh S; Min YJ; Park SH; Lee SH; Kim HJ; Choi Y
Support Care Cancer; 2021 Feb; 29(2):975-986. PubMed ID: 32556712
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of lung transplantation after allogeneic hematopoietic stem cell transplantation.
Cheng GS; Edelman JD; Madtes DK; Martin PJ; Flowers ME
Biol Blood Marrow Transplant; 2014 Aug; 20(8):1169-75. PubMed ID: 24727334
[TBL] [Abstract][Full Text] [Related]
3. Quality of Life following Allogeneic Stem Cell Transplantation for Patients Age >60 Years with Acute Myelogenous Leukemia.
Wright R; Oremek M; Davies D; Kewley C; Singh A; Taitt N; Kempshall E; Wilson K; Ingram W
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1527-1533. PubMed ID: 32422252
[TBL] [Abstract][Full Text] [Related]
4. Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study.
Gifford G; Sim J; Horne A; Ma D
Intern Med J; 2014 Feb; 44(2):139-47. PubMed ID: 24320824
[TBL] [Abstract][Full Text] [Related]
5. The quality of life following allogeneic hematopoietic stem cell transplantation - a multicenter retrospective study.
Valkova V; Jircikova J; Trnkova M; Steinerova K; Keslova P; Lanska M; Koristek Z; Raida L; Krejci M; Kruntoradova K; Dolezal T; Benesova K; Cetkovsky P; Trneny M
Neoplasma; 2016; 63(5):743-51. PubMed ID: 27468878
[TBL] [Abstract][Full Text] [Related]
6. Surviving the cure: long term followup of hematopoietic cell transplant recipients.
Majhail NS; Rizzo JD
Bone Marrow Transplant; 2013 Sep; 48(9):1145-51. PubMed ID: 23292238
[TBL] [Abstract][Full Text] [Related]
7. Predictors of post traumatic growth in allogeneic hematopoietic stem cell transplantation survivors: a cross-sectional survey.
McErlean G; Tapp C; Brice L; Gilroy N; Kabir M; Greenwood M; Larsen SR; Moore J; Gottlieb D; Hertzberg M; Brown L; Hogg M; Huang G; Ward C; Kerridge I
BMC Psychol; 2023 Aug; 11(1):235. PubMed ID: 37587508
[TBL] [Abstract][Full Text] [Related]
8. Does anti-thymocyte globulin have a place in busulfan/fludarabine conditioning for matched related donor hematopoietic stem cell transplantation?
Ji YS; Lee MS; Min CW; Park SK; Kim SH; Yun J; Kim HJ; Kim KH; Kim CK; Lee KT; Won JH; Hong DS
Korean J Intern Med; 2016 Jul; 31(4):750-61. PubMed ID: 27017944
[TBL] [Abstract][Full Text] [Related]
9. Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Patients Age >69 Years with Acute Myelogenous Leukemia: On Behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Ringdén O; Boumendil A; Labopin M; Canaani J; Beelen D; Ehninger G; Niederwieser D; Finke J; Stelljes M; Gerbitz A; Ganser A; Kröger N; Kantz L; Brecht A; Savani B; Sadeghi B; Mohty M; Nagler A
Biol Blood Marrow Transplant; 2019 Oct; 25(10):1975-1983. PubMed ID: 31181255
[TBL] [Abstract][Full Text] [Related]
10. Spermatogenesis in long-term survivors after allogeneic hematopoietic stem cell transplantation is associated with age, time interval since transplantation, and apparently absence of chronic GvHD.
Rovó A; Tichelli A; Passweg JR; Heim D; Meyer-Monard S; Holzgreve W; Gratwohl A; De Geyter C
Blood; 2006 Aug; 108(3):1100-5. PubMed ID: 16543466
[TBL] [Abstract][Full Text] [Related]
11. Haematopoietic stem cell transplantation survivorship and quality of life: is it a small world after all?
Brice L; Gilroy N; Dyer G; Kabir M; Greenwood M; Larsen S; Moore J; Kwan J; Hertzberg M; Brown L; Hogg M; Huang G; Tan J; Ward C; Gottlieb D; Kerridge I
Support Care Cancer; 2017 Feb; 25(2):421-427. PubMed ID: 27699502
[TBL] [Abstract][Full Text] [Related]
12. Late Complications and Quality of Life after Reduced-Intensity Conditioning Allogeneic Stem Cell Transplantation.
Clavert A; Peric Z; Brissot E; Malard F; Guillaume T; Delaunay J; Dubruille V; Le Gouill S; Mahe B; Gastinne T; Blin N; Harousseau JL; Moreau P; Milpied N; Mohty M; Chevallier P
Biol Blood Marrow Transplant; 2017 Jan; 23(1):140-146. PubMed ID: 27751934
[TBL] [Abstract][Full Text] [Related]
13. Effects of Late Toxicities on Outcomes in Long-Term Survivors of Ex-Vivo CD34
Scordo M; Shah GL; Kosuri S; Herrera DA; Cho C; Devlin SM; Maloy MA; Nieves J; Borrill T; Avecilla ST; Meagher RC; Carlow DC; O'Reilly RJ; Papadopoulos EB; Jakubowski AA; Koehne G; Gyurkocza B; Castro-Malaspina H; Tamari R; Perales MA; Giralt SA; Shaffer BC
Biol Blood Marrow Transplant; 2018 Jan; 24(1):133-141. PubMed ID: 28870777
[TBL] [Abstract][Full Text] [Related]
14. Outcome and late effects among acute myeloid leukemia survivors: a nationwide population-based study.
Chang KH; Hwang WL; Muo CH; Hsu CY; Teng CJ
Support Care Cancer; 2016 Dec; 24(12):4993-5000. PubMed ID: 27502072
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic characteristics of secondary squamous cell carcinoma of head and neck in survivors of allogeneic hematopoietic stem cell transplantation for hematologic malignancies.
Chaulagain CP; Sprague KA; Pilichowska M; Cowan J; Klein AK; Kaul E; Miller KB
Bone Marrow Transplant; 2019 Apr; 54(4):560-566. PubMed ID: 30127467
[TBL] [Abstract][Full Text] [Related]
16. Who Is a Better Donor for Recipients of Allogeneic Hematopoietic Cell Transplantation: A Young HLA-Mismatched Haploidentical Relative or an Older Fully HLA-Matched Sibling or Unrelated Donor?
Karam E; Laporte J; Solomon SR; Morris LE; Zhang X; Holland HK; Bashey A; Solh MM
Biol Blood Marrow Transplant; 2019 Oct; 25(10):2054-2060. PubMed ID: 31173900
[TBL] [Abstract][Full Text] [Related]
17. Myeloablative allogeneic hematopoietic stem cell transplantation for Philadelphia chromosome-positive acute lymphoblastic leukemia in adults: significant roles of total body irradiation and chronic graft-versus-host disease.
Yanada M; Naoe T; Iida H; Sakamaki H; Sakura T; Kanamori H; Kodera Y; Okamoto S; Kanda Y; Sao H; Asai O; Nakai K; Maruta A; Kishi K; Furukawa T; Atsuta Y; Yamamoto K; Tanaka J; Takahashi S
Bone Marrow Transplant; 2005 Nov; 36(10):867-72. PubMed ID: 16113659
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic HSCT for autoimmune diseases: conventional conditioning regimens.
Nash RA
Bone Marrow Transplant; 2003 Aug; 32 Suppl 1():S77-80. PubMed ID: 12931249
[TBL] [Abstract][Full Text] [Related]
19. A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia.
Dyer G; Gilroy N; Brice L; Kabir M; Gottlieb D; Huang G; Hogg M; Brown L; Greenwood M; Larsen SR; Moore J; Hertzberg M; Tan J; Ward C; Kerridge I
Transpl Infect Dis; 2019 Apr; 21(2):e13043. PubMed ID: 30585673
[TBL] [Abstract][Full Text] [Related]
20. Determinants of cardiorespiratory fitness in very long-term survivors of allogeneic hematopoietic stem cell transplantation: a national cohort study.
Myrdal OH; Diep PP; Ruud E; Brinch L; Massey RJ; Edvardsen E; Kongerud J; Lund MB; Sikkeland LI
Support Care Cancer; 2021 Apr; 29(4):1959-1967. PubMed ID: 32827056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
